Hematology and Blood Disorders

Advances in Hemostasis and Thrombosis

The Advances in Hemostasis and Thrombosis track at the 21st Global Summit on Hematology and Blood Disorders (Blood Disorder 2025) will spotlight recent progress and innovations in the understanding and management of bleeding and clotting disorders. Researchers are invited to submit abstracts that explore cutting-edge developments in anticoagulant therapies, novel diagnostic tools, and advancements in the treatment of both congenital and acquired hemostatic disorders. The track will feature in-depth presentations on emerging therapies, including new anticoagulants and treatments for thrombosis, as well as advancements in the management of bleeding disorders.

Attendees can expect to gain insights from leading experts on the latest clinical and research findings, engage in interactive discussions on practical applications, and explore strategies for optimizing patient care. Additionally, the track offers valuable networking opportunities, enabling participants to connect with peers and leaders in the field, fostering collaborative efforts to address current challenges and advance treatment approaches. This track aims to enhance understanding of recent innovations and their implications for clinical practice in hemostasis and thrombosis.